Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial

医学 丝裂霉素C 泌尿系统 膀胱癌 危险系数 泌尿科 内科学 胃肠病学 置信区间 癌症 外科
作者
Yasuyoshi Miyata,Toshifumi Tsurusaki,Yoshiko Hayashida,Yushi Imasato,Kosuke Takehara,Daiyu Aoki,Masaharu Nishikido,Junichi Watanabe,Kensuke Mitsunari,Tomohiro Matsuo,Kenkichi Ohba,Keisuke Taniguchi,Hideki Sakai
出处
期刊:BJUI [Wiley]
卷期号:129 (4): 534-541 被引量:6
标识
DOI:10.1111/bju.15571
摘要

To compare the urinary pH, recurrence-free survival (RFS), and safety of adjuvant intravesical therapy in patients with non-muscle-invasive bladder cancer (NMIBC) receiving mitomycin C (MMC) therapy and MMC + cytosine arabinoside (Ara-C) therapy.A total of 165 patients with NMIBC from six hospitals were randomly allocated to two groups: weekly instillation of MMC + Ara-C (30 mg/30 mL + 200 mg/10 mL) for 6 weeks and the same instillation schedule of MMC (30 mg/40 mL). The primary outcome was RFS, and secondary outcomes were urinary pH and toxicity in the two groups.A total of 81 and 87 patients were randomised into the MMC and MMC + Ara-C groups, respectively. Overall, the RFS in the MMC + Ara-C group was significantly longer (P = 0.018) than that in the MMC group. A similar significant difference was detected in patients with intermediate-risk NMIBC, but not in those with high-risk NMIBC. The mean (SD) urinary pH was significantly higher in the MMC + Ara-C group than in the MMC group, at 6.56 (0.61) vs 5.78 (0.64) (P < 0.001), and the frequency of a urinary pH of >7.0 in the MMC and MMC + Ara-C groups was 6.3% and 26.7%, respectively (P < 0.001). Multivariate analysis models including clinicopathological features and second transurethral resection demonstrated that increased urinary pH was associated with better outcomes (hazard ratio 0.18, 95% confidential interval 0.18-0.038; P < 0.001). In all, there were 14 and 10 adverse events in the MMC and MMC + Ara-C groups, respectively, without a significant difference (P = 0.113).Our randomised clinical trial suggested that intravesical therapy with MMC and Ara-C is useful and safe for patients with intermediate-risk NMIBC. Increase in urinary pH with Ara-C is speculated as a mechanism for increased anti-cancer effects.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
酷波er应助钱小二采纳,获得10
刚刚
刚刚
SciGPT应助爬山虎采纳,获得10
刚刚
刚刚
zhangzzzz发布了新的文献求助10
刚刚
院士发布了新的文献求助10
刚刚
無心完成签到,获得积分10
1秒前
自由风发布了新的文献求助10
2秒前
1111111完成签到,获得积分10
2秒前
小吕小吕完成签到,获得积分10
3秒前
我是老大应助苹果邪欢采纳,获得10
3秒前
3秒前
4秒前
Yang发布了新的文献求助50
4秒前
4秒前
笨笨中心发布了新的文献求助10
5秒前
5秒前
害羞猫咪发布了新的文献求助30
6秒前
NexusExplorer应助n1gern采纳,获得10
6秒前
mimi3358发布了新的文献求助10
6秒前
科研通AI2S应助1111111采纳,获得10
6秒前
7秒前
8秒前
橡树完成签到,获得积分10
8秒前
8秒前
思源应助学术通zzz采纳,获得10
9秒前
NSS完成签到 ,获得积分10
10秒前
华仔应助柳易槐采纳,获得10
10秒前
10秒前
小蔡要加辣应助寒霁采纳,获得10
10秒前
zhangzzzz完成签到,获得积分10
10秒前
11秒前
哈欠完成签到,获得积分10
11秒前
F123456发布了新的文献求助10
12秒前
wayhome发布了新的文献求助10
12秒前
所所应助ZSY采纳,获得10
12秒前
12秒前
12秒前
大个应助嘉人采纳,获得10
13秒前
lycoris完成签到,获得积分10
13秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961351
求助须知:如何正确求助?哪些是违规求助? 3507711
关于积分的说明 11137438
捐赠科研通 3240131
什么是DOI,文献DOI怎么找? 1790762
邀请新用户注册赠送积分活动 872504
科研通“疑难数据库(出版商)”最低求助积分说明 803271